Detection of False Positives From First-trimester Preeclampsia Screening (StopPRE) at the Second-trimester of Pregnancy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The main objective of the study is to demonstrate that in patients considered to be at high risk for PE (from the first‐trimester screening) and with sFlt‐1/PlGF ratio <38, between 24+0 and 27+6 weeks, the incidence of preterm PE, after cessation of the treatment with ASA, will not be superior to that of the control group.
Epistemonikos ID: f6f397111b3cce5cf442ce12f27db410cca9b370
First added on: May 21, 2024